Experimental treatment of chronic Trypanosoma cruzi infection in mice with 2-N-propylquinoline

Phytotherapy Research

Volumn 15, Issue 7, 2001, Pages 630-632

  Nakayama, Hector ^a   Ferreira, Maria Elena ^a   De Arias, Antonieta Rojas ^b   De Bilbao, Ninfa Vera ^b   Torres, Susana ^b   Schinini, Alicia ^a   Fournet, Alain ^a  

^a Instituto de Investigaciones en Ciencias de la Salud   (Paraguay)

^b INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

2 n propylquinoline; 2 substituted quinoline; Chagas' disease; Chronic infection; Experimental treatment; Trypanosoma cruzi

Indexed keywords

2 N PROPYLQUINOLINE; BENZNIDAZOLE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIMASTIGOTE; FEMALE; MALE; MOUSE; NONHUMAN; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; CHAGAS DISEASE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MALE; MICE; MICE, INBRED BALB C; NITROIMIDAZOLES; PHYTOTHERAPY; PLANT EXTRACTS; QUINOLINES; RUTACEAE; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 0034763934     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.877     Document Type: Article

References (12)

1. Ramdomised trial of efficacy of benznidazole in the treatment of early Trypanosoma cruzi infection
2. Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi genome project
3. Antiprotozoal activity of quinoline alkaloids isolated from Galipea longiflora, a Bolivian plant used as a treatment for cutaneous leishmaniasis
4. In vivo efficacy of 2-substituted quinolines in experimental treatment of New World cutaneous leishmaniasis caused by Leishmania amazonensis
5. Aryl-2 et alkyl-2 quinoléines nouvelles isolées d'une rutacée bolivienne: Galipea longiflora
6. Primaquine analogues that are potent anti-Trypanosoma cruzi agents in a mouse model
7. Evidence that certain 8-aminoquinolines are potentially drugs against Chagas' disease
8. Cleavage of structural proteins during the assembly of the head bacteriophage T4
9. Tratamiento especifico de la enfermedad de Chagas en la fase cronica: Criterios de cura convencionales: Xenodiagnostico, hemocultivo y serologia
10. Cross-reactivity and differential sero-diagnosis of human infections caused by Trypanosoma cruzi and Leishmania ssp. use of immunoblotting and ELISA with purified antigen (Ag163B6)
11. On Chagas disease and leishmaniasis
12. Tropical disease research, progress 1975-94, Highlights 1993-94